Adheris Health Limited, operating as MedAdvisor Solutions, is an Australian-based digital health technology company specializing in pharmacy-driven patient engagement solutions across Australia, the United States, the United Kingdom, and New Zealand. The company’s core business is dedicated to simplifying the patient medication journey and improving health outcomes by leveraging its advanced cloud-based, AI-enabled THRiV platform. This comprehensive omni-channel platform offers a robust suite of products, including a Medication Management Application that connects patients directly with their pharmacies for services like refills and reminders, the PlusOne Pharmacy Software designed to streamline pharmacy operations and patient communications, and a specialized Pharma Patient Experience Platform for pharmaceutical companies. These integrated solutions are engineered to enhance pharmacy workflow, provide personalized patient and pharmacist engagement, and significantly support medication adherence through targeted messaging and interactive tools. MedAdvisor Solutions maintains a significant geographic presence, partnering with over 37,000 pharmacies across its key markets; notably, it has connected over 3.7 million patients through more than 95% of Australian pharmacies and reaches over two-thirds of the US population. By utilizing data-driven and AI-powered approaches, the company delivers timely medication information, reminders, and support, thereby inspiring lasting behavioral change, fostering medication adherence, and optimizing patient care for both pharmacies and pharmaceutical companies, ultimately aiming to empower pharmacies to provide expanded patient services and manage medications more effectively within the evolving healthcare landscape.
Join +20,000 subscribers receiving alerts.
Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.
StockWire X delivers fast, reliable, and actionable insights into significant developments across global markets, with coverage spanning technology, biotechnology, healthcare, financials, and emerging industries. Our mission is to provide clear, data-driven content that empowers investors to identify opportunities and make informed decisions ahead of the market.
Our network spans key financial and investment hubs worldwide, ensuring subscribers receive timely updates on market-moving announcements, news, macroeconomic trends, and corporate developments.
Use of Technology
We harness advanced technologies to enhance the speed, accuracy, and relevance of our reporting.
While technology accelerates our workflow, every piece of content is selected, validated, and published by human professionals, in accordance with best practices for accuracy, transparency, and investor value. This hybrid approach ensures speed without compromising editorial integrity.
Feedback and Accuracy
We are committed to accuracy and fairness in our reporting. If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
StockWire X provides readers with access to market news, educational content, and commentary from financial services professionals, industry experts, and companies (“Contributors”).
StockWire X does not hold an Australian Financial Services Licence (AFSL) and relies on the exemption available under section 911A(2)(eb) of the Corporations Act 2001 (Cth) in respect of any financial product advice provided.
Any advice or information published by StockWire X is general in nature only and has been prepared without taking into account your personal objectives, financial situation, or needs. Before acting on any information, you should consider whether it is appropriate for your circumstances and seek independent, licensed financial advice. You should also obtain and read any relevant Product Disclosure Statement (PDS) or other offer document before making an investment decision.
StockWire X makes no guarantee as to the accuracy, completeness, or timeliness of the information provided, and accepts no responsibility for any loss arising from reliance on it. All content is published in good faith for informational purposes only.
StockWire X may have commercial relationships with some contributors or companies mentioned in our content. Any such relationships will be disclosed where relevant.
If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
